Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emmanuel Peyronnet"'
Autor:
Adèle L’Hostis, Jean-Louis Palgen, Angélique Perrillat-Mercerot, Emmanuel Peyronnet, Evgueni Jacob, James Bosley, Michaël Duruisseaux, Raphaël Toueg, Lucile Lefèvre, Riad Kahoul, Nicoletta Ceres, Claudio Monteiro
Publikováno v:
npj Systems Biology and Applications, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Lung adenocarcinoma (LUAD) is associated with a low survival rate at advanced stages. Although the development of targeted therapies has improved outcomes in LUAD patients with identified and specific genetic alterations, such as activating
Externí odkaz:
https://doaj.org/article/3e54093f844f49948535eddc19fa9f5f
Autor:
Adèle L'Hostis, Jean-Louis Palgen, Angélique Perrillat-Mercerot, Emmanuel Peyronnet, Evgueni Jacob, James R. Bosley, Michaël Duruisseaux, Raphaël Toueg, Lucile Lefèvre, Riad Kahoul, Nicoletta Ceres, Claudio Monteiro
Lung adenocarcinoma (LUAD) is associated with a low survival rate at advanced stages. Although the development of targeted therapies has improved the survival of LUAD patients with identified and specific genetic alterations, such as mutations on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83a4196c81bb29689085789ae8f8c3a0
https://doi.org/10.21203/rs.3.rs-2405647/v1
https://doi.org/10.21203/rs.3.rs-2405647/v1
Autor:
Jean-Louis Palgen, Angélique Perrillat-Mercerot, Nicoletta Ceres, Emmanuel Peyronnet, Matthieu Coudron, Eliott Tixier, Ben M. W. Illigens, Jim Bosley, Adèle L’Hostis, Claudio Monteiro
Mechanistic models are built using knowledge as the primary information source, with well-established biological and physical laws determining the causal relationships within the model. Once the causal structure of the model is determined, parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c36139d6862b3e25c07a7cd741971b
https://doi.org/10.1101/2022.01.17.476676
https://doi.org/10.1101/2022.01.17.476676
Autor:
Michael Duruisseaux, Adèle L'Hostis, Emmanuel Peyronnet, Evgueni Jacob, Ben M.W. Illigens, Jim Bosley, Riad Kahoul, Jean-Louis Palgen, Claudio Monteiro
Publikováno v:
Cancer Research. 82:3362-3362
Introduction: Non-small cell lung cancer (NSCLC) response to gefitinib depends on epidermal growth factor receptor (EGFR) mutational status. Response differs according to tumor heterogeneity, notably through clonal selection according to genetic back
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5441d5651156f72f24d8e362d75bf5ec
https://doi.org/10.1158/1538-7445.am2022-3362
https://doi.org/10.1158/1538-7445.am2022-3362
Autor:
Adèle L'Hostis, Jean-Louis Palgen, Nicoletta Ceres, Angelique Perrillat-Mercerot, Emmanuel Peyronnet, Evgueni Jacob, Riad Kahoul, Matthieu Coudron, Lucile Lefevre, Raphael Toueg, Andreea Todea, Marc Hommel, Jean-Pierre Boissel, Jim Bosley, Michaël Duruisseaux, Claudio Monteiro
Publikováno v:
Journal of Clinical Oncology. 40:e20565-e20565
e20565 Background: Tumor heterogeneity and treatment resistance remains a continued threat to patients with advanced non-small cell lung cancer (NSCLC), despite the emergence of targeted medicines, e.g. against epidermal growth factor receptor (EGFR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b0cf8229ca52fa223ed890d76a814b3
https://doi.org/10.1200/jco.2022.40.16_suppl.e20565
https://doi.org/10.1200/jco.2022.40.16_suppl.e20565